4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with indomethacin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bissonnette, EY; Castonguay, A; Proulx, LI; Therriault, MJ | 1 |
1 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and indomethacin
Article | Year |
---|---|
Immunomodulatory effects of the tobacco-specific carcinogen, NNK, on alveolar macrophages.
Topics: Animals; Antibodies, Monoclonal; Carcinogens; Cell Line; Chemokine CCL3; Chemokine CCL4; Cyclooxygenase Inhibitors; Depression, Chemical; Dinoprostone; Dose-Response Relationship, Drug; Indomethacin; Interleukin-10; Interleukin-12; Lipopolysaccharides; Macrophage Inflammatory Proteins; Macrophages, Alveolar; Nitric Oxide; Nitrobenzenes; Nitrosamines; Pyridines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Smoking; Sulfonamides; Time Factors; Tumor Necrosis Factor-alpha | 2003 |